Aprepru
Laufzeit: 01.01.2015 - 31.12.2017
imported
Kurzfassung
Aprepitant in histamine-refractory chronic pruritus: a multicenter, randomized, double-blind, placebo-controlled, cross-over, phase II trial
Laufzeit: 01.01.2015 - 31.12.2017
Aprepitant in histamine-refractory chronic pruritus: a multicenter, randomized, double-blind, placebo-controlled, cross-over, phase II trial
